introduCtion
In contemporary medicine, number-based assessment tools are frequently used to evaluate the perception of pain in both acute and chronic pain patients and to determine the effect of pain management 1 . Most popular methods are the visual analogue scale (VAS) and numerical rating scale (NRS), as these are simple and equally sensitive methods that are considered superior to categorical pain scales (e.g., none, mild, moderate, and severe pain) or narrative reports of pain 1, 2 . For the NRS, patients are instructed to verbally rate their pain's quality (this can be any of many pain-related dimensions such as pain intensity or satisfaction with pain relief ) on an 11-point scale ranging from 0 (no pain perceived) to 10 (worst intense pain imaginable or tolerable) 1 . Although simple in theory, the use of a numerical scale in the rating of pain requires the ability of the patient to translate a sensory stimulus into a relative number on an abstract pain scale. This is a rather complex task, and, additionally, rating pain up to "the worst pain imaginable" is a concept that requires an intuitive imagination and an adequate memory of previous pains endured. Nevertheless, various validation studies show that patients are able to use numerical pain-rating scales to adequately score their pain and quantify the effect of pain management [3] [4] [5] [6] [7] . Rating scores on a VAS or NRS are considered the gold standard of pain testing 6 . Still, the use of numerical scoring systems may be affected by changes in cognition induced by diseases such as chronic pain or by drugs that act at the central nervous system such as opioids. Wolrich et al. 8 made an important observation in this respect. They showed that the ability of number sensing, i.e., the ability to name and mark a number, is negatively affected in chronic pain patients more than in acute pain patients, possibly because of functional changes in brain areas involved in understanding numbers and their proportions 8 . This may particularly affect the ability of chronic pain patients to score pain using VAS or NRS.
The primary aim of this study was to determine the ability of chronic and acute postoperative pain patients to adequately score their response to randomly applied noxious stimuli on the NRS relative to healthy sex-matched and age-matched controls and to assess the effect of treatment with opioids. After defining experimental pain threshold (NRS = 1) and pain tolerance (NRS = 10), 8 noxious stimuli, in intensity linearly distributed in between NRS 1 and 10, were applied in a randomized blinded fashion and the NRS was recorded. The data were then analyzed using a penalty score system based on the assumption that stimuli of higher intensity should be scored with a greater NRS.
The second aim of the study was to assess the linearity of the stimulus-NRS relationship. Some studies suggest that the numerical pain scales are linear, whereas others suggest a sigmoid relationship [9] [10] [11] . This is an important issue, as only a linear relationship will allow treatment of numerical scales as ratios or percentage change. We applied population-based mixed-effects models on the stimulus-response data to determine linearity of the relationship in healthy controls, chronic and acute pain patients.
methods
The study was performed after approval was obtained from the LUMC Human Ethics Committee (Commissie Medische Ethiek, Leiden University Medical Center, 2300 RC Leiden, the Netherlands) from January 2013 to October 2014. The protocol was registered in the Netherlands Trial Register under number 3769. All patients gave oral and written informed consent before enrolment into the study.
Participants
Healthy volunteers without pain (controls, n = 37), chronic pain patients (n = 30), and American Society of Anesthesiologists (ASA) class I and 2 surgical patients (n = 62) participated in the study. Exclusion criteria were age <18 years, body mass index >35 kg/m 2 , presence of a medical condition (such as systemic, cardiovascular, pulmonary, renal, liver, or infectious disease), pregnancy or lactation, and history of illicit drug or alcohol abuse. For controls and surgical patients, the presence of an acute or chronic pain syndrome or the use of pain relief medication (excluding acetaminophen) in the 6 months before the study were additional exclusion criteria. All chronic pain patients were diagnosed with fibromyalgia and included if they had an NRS pain score ≥5 for most of the day and met the 2010 American College of Rheumatology diagnostic criteria 12, 13 . These criteria included a widespread pain index (WPI) ≥7 (on a scale from 0 to 19) and a symptom severity (SyS) score ≥5 (on a scale from 0 to 12) or a WPI of 3 to 6 and a SyS score ≥9. The WPI defines the number of body areas in which a patient experienced pain during the last week; the SyS score indicates the level of other core symptoms of fibromyalgia such as fatigue, nonrefreshing sleep, and cognitive symptoms. Additionally, tender point examinations were performed according to the 1990 American College of Rheumatology diagnostic criteria 14 ; however, these results were not considered for inclusion or exclusion. The presence of autonomic complaints such as diarrhea or obstipation, dizziness, and dry mouth/eyes was no reason for exclusion in the chronic pain patient group, as these are symptoms consistent with the fibromyalgia syndrome 12 . In chronic pain patients, the presence of pain syndromes other than fibromyalgia was a final exclusion criterion for entrance in the study. Controls and chronic pain patients were instructed to refrain from taking any medication and consuming alcohol, caffeinated beverages or caffeinated foods on the days of the experiment. Preoperative preparation of the surgical patients was according to local protocol.
nociceptive assays and pain scoring
Controls and chronic pain patients underwent 2 pain tests: nociceptive thermal and nociceptive electrical testing. Heat and electrical pain stimuli were alternated with a 3 to 5 minutes resting period maintained between tests. For logistic reasons of which time constraints were most important, surgical patients underwent electrical pain testing only.
Nociceptive thermal stimulation
Heat pain was induced by placing a 3 × 3 cm thermal probe (Pathway Neurosensory Analyzer; Medoc Ltd, Ramat Yishai, Israel) on the volar side of the right forearm of the subject. Temperatures increased by 6°C per second from a baseline temperature of 32°C to a preset target temperature that was maintained for 5 seconds. Subjects were instructed to score the highest pain sensation they felt during the stimulation. To overcome adaptation or sensitization, the stimulus zone was divided into 3 separate blocks, which were used sequentially 15 . Heat stimulations at the same skin site occurred at 25 to 30 minutes intervals.
Nociceptive electrical stimulation
Electrical pain was induced by placing 2 electrodes (surface area, 0.8 cm 2 ; space between the electrodes, 2 cm) on the tibial surface of the right leg. Electrical currents were applied using a locally designed and constructed computer interfaced current stimulator (CICS, Leiden University Medical Center, Leiden, the Netherlands) 15 . A preset constant current (a 5-second train of 200 µs pulses at a frequency of 10 Hz) was delivered to the skin, and subjects were instructed to score the highest pain sensation they felt during the stimulation.
Pain scoring
All participants were initially familiarized with the study design, pain tests, and scoring system. Pain intensity was scored using an 11-point NRS ranging from 0 (no pain) to 10 (worst pain imaginable). Only integers were allowed for scoring. The first part of the study was the accurate assessment of pain threshold (PTh, NRS = 1) and pain tolerance (PTol, NRS = 10). This was performed for heat and electrical pain. To define PTh, a subthreshold stimulus lasting 5 seconds was applied (39°C and 8 mA) and the NRS was scored. Next in steps of 0.5°C and 0.5 mA, the stimuli were increased in intensity. The lowest value causing an NRS of 1 was used as PTh. For pain tolerance, a similar approach was applied, with the lowest temperature and current causing an NRS of 10 as PTol set point. This procedure was repeated 2 to 3 times to be certain of a reliable estimation of PTh and PTol. The procedure was ended when the sequential estimates were within ±0.5°C and ±0.5 mA. 
study design
Stimulus-response data were obtained in all participants under baseline conditions (without the administration of any opioids) and in most participants during administration of opioid medication.
Controls and chronic pain patients
Twenty controls and all chronic pain patients received a continuous intravenous infusion of alfentanil on one occasion and no treatment (NoT) on the other. Sessions were randomized with at least 1 week between experiment days; time of testing was similar on both sessions. Alfentanil (Rapifen; Janssen-Cilag BV, Tilburg, the Netherlands) was administered using a target controlled infusion system (Orchestra Base Primea; Fresenius Kabi, Zeist, the Netherlands) programmed with the alfentanil pharmacokinetic set of Maitre et al. 16 . The participants were infused for 2 hours at a target concentration of 200 ng/mL. This concentration was chosen as it provides robust analgesia without causing serious side effects. Seventeen additional controls participated on one occasion and received no analgesic medication during testing. Testing was performed during the later part of the infusion (from t = 40 to t = 120 minutes) when stable alfentanil concentrations were assumed.
Surgical patients All patients were tested before surgery on the day of operation. Premedication consisted of 1000 mg oral acetaminophen just before testing; no sedative or opioid premedication was allowed. Thirty minutes after arrival in the postanesthesia care unit, the patients were retested. Only patients with a Ramsay sedation score of 2 were tested. Spontaneous pain scores before the stimulus-response tests were noted. All patients received intravenous bolus morphine or methadone infusions for acute pain relief.
data and statistical analyses
The deviation of stimulus-response relationship to an ideal relationship ( Fig. 1A ) was calculated by subtracting each pain score (j) from the previous score (j − 1), d(j) = NRS(j) − NRS(j − 1). Next, the value of d was translated into a penalty score rather than into an error score. In both regression and prediction analyses, errors are taken into account by their squared values. However, this would also penalize scores going in the expected direction on an increase or decrease in stimulation. The penalty score awards points to a negative (unwanted) event and is an objective tool for the assessment of the general performance of a system in which specific performances are expected such as in our case increasing NRS values at increasing stimulus intensities. Deviations from the expected performance receive penalty scores, which are defined as follows: (1) if d(j) > 0 (ie, a stimulus j with a higher intensity is perceived as more painful than the stimulus with the lower intensity j-1), no penalty was applied, (2) if d(j) = 0 (ie, a stimulus j with a higher intensity is perceived as equally painful than the stimulus with the lower intensity j-1), a penalty of 0.5 points was applied, (3) if d(j) < 0 (ie, a stimulus j with a higher intensity is perceived as less painful than the stimulus with the lower intensity j-1), a penalty of the observed change in score, ie, d(j) was applied. Worst observed score for the heat pain test with a summed penalty score of 13.5 in a chronic pain patient during the administration of alfentanil. The patient did not reach pain tolerance at a temperature ≤52°C (cutoff ). Consequently, the NRS value observed at 52°C (in this case an NRS of 7) was set as upper limit and a linear distribution of 8 interpolated temperatures was made between the pain threshold temperature and 52°C. (E) Best observed score for the heat pain test with a summed penalty score of 1.5 in a chronic pain patient under baseline conditions. NRS is numerical rating score.
The total penalty score is the sum of all separate penalty scores, i.e., from j = 2 (the first measurement above PTh) to j = 10 (PTol). Theoretically the summed penalty scores range from 0 (a perfect ever increasing NRS) to 40 (a score that depicts the maximum penalty score), see also Figure 1 . On the basis of a blinded visual check of the complete data set, we divided the summed penalty scores into 3 cohorts, representing "good," "mediocre," and "poor" stimulus-response relationships, with respective sum scores ≤3.5 (good), 4 to 7 (mediocre) and ≥7.5 (poor). Separate summed penalty scores were obtained for each session (no treatment or baseline, opioid, preoperative, postoperative) and nociceptive assay (heat, electrical). The penalty scores were analyzed using IBM SPSS statistics version 20. All data analyses were by nonparametric tests. Fisher's exact tests were used to assess whether the distributions of subjects over the summed penalty score classes good, mediocre, and poor scores were different among groups and to determine whether the distributions of penalty score classes were influenced by opioid use. The presence of sex differences was assessed by the Mann-Whitney U exact test; age effects were evaluated by Spearman's ρ.
To assess the linearity of the stimulus-response relationship, 2 models were fitted to the data. (1) A linear function with parameters S1 and S10, which are the values of the stimulus (current or temperature) yielding an NRS of 1 and 10, respectively; (2) a sigmoidal function with parameters N5 and shape parameter γ, where N5 is the value of the stimulus yielding an NRS of 5. Opioid effect was assessed by a multiplicative factor Z where N5(opioid) = Z × N5(baseline). The fact that the NRSs are integers between 0 and 10 was addressed by assuming an underlying normally distributed variable. Nonlinear mixed-effects analysis by NONMEM (a statistical package for nonlinear mixed-effects modelling; ICON Development Solutions, Hanover, MD) 17 was performed, and the difference between the minimum values of the objective function using the linear and nonlinear models was inspected to test the linearity of the stimulus-NRS response relationship.
results subjects
Thirty-seven healthy controls, 30 chronic pain patients and 62 surgical patients participated in the study. The age range of participants was similar for healthy controls (n = 37, age range: 18-57 years) and chronic pain patients (n = 30, 19-58 years); acute pain patients were on average older (n = 61, 21-84 years). See Table 1 -311 minutes) . At the moment of testing, the average postoperative pain score in the 42 tested patients was 4.0 (95% confidence interval 3.1-4.9). All participants completed the study without any unforeseen adverse effects. Baseline heat pain thresholds and tolerances were in controls: 43.1 ± 2.0°C (mean ± SD) and 50.7 ± 1.5°C and in chronic pain patients: 42.2 ± 2.7°C and 48.6 ± 1.9°C. Electrical pain thresholds and tolerances were in controls: 11.5 ± 3.5 mA and 27.6 ± 9.2 mA, in chronic pain patients: 11.4 ± 6.2 mA and 25.1 ± 13.6 mA, and in preoperative surgical patients: 13.9 ± 6.0 mA and 36.8 ± 17.7 mA. Opioid treatment caused an increase in threshold and tolerance values; the effect was largest for the electrical pain test (Table 1) . 
Penalty scores
Examples of stimulus-response data are given in Figure 1 . Baseline (no treatment) penalty scores ranged from 1.5 to 9 (heat pain) and 1.0 to 8.5 (electrical pain) in healthy controls. Corresponding ranges for chronic pain patients were 1.5 to 8.0 (heat pain) and 1.5 to 13.0 (electrical pain). In surgical patients, the scores ranged from 1.0 to 18.5. Heat pain seemed to be more difficult to assess than electrical pain with more individuals with higher penalty scores for heat pain than for electrical pain scores (P = 0.03 in controls and P = 0.04 in chronic pain patients, Table 2 ). In none of the study populations, a significant age or sex effect on the penalty scores could be detected (data not shown). Penalty score distributions observed under baseline conditions (ie, without opioid treatment) are given in Figure 2 and Table 2 . Baseline scores differed significantly between healthy controls and chronic pain patients for heat pain tests with 27% (controls) vs. 55.1% (chronic pain patients) of scores >3.5 (Χ 2 Fisher's exact test: P = 0.03) but not for electrical pain tests (P = 0.46). Preoperative scores from electrical testing in surgical patients did not differ from the scores of healthy controls (P = 0.33) or chronic pain patients (P = 0.44). To assess whether subjects were consistent in their scoring ability between heat and electrical pain testing, contingency tables were created (Table 3) . Healthy controls performed best in the 2 nociceptive assays with 68% overlap in scoring between heat pain and electrical pain (with 60% of scores in cohort "good"). In contrast, 
opioid effect on stimulus-response relationship
Opioids negatively influenced heat pain scoring in both controls and chronic pain patients (Table 2 and Fig. 3 ) with a significant shift in distribution towards higher penalty scores in controls (P = 0.02) and chronic pain patients (P = 0.02). These effects were not observed for the electrical nociceptive assay in any of the study population (controls P = 0.77, chronic pain patients P = 0.13, postoperative patients P = 0.45; Table 2 ). There was good correspondence between preoperative and postoperative scores in surgical patients with an overlap of 57.2% (52.4% in cohort "good"; Table 3 ).
nonlinearity of stimulus-response relationship
For both electrical and heat pain, the sigmoidal model of the stimulus-response data provided a significantly better fit compared with the linear model with a difference in the objective function value of more than 100 (P < 0.0001). Parameter estimates of the sigmoidal model are given in Table 4 . In Figure 4 , examples of data fits and population fits obtained under baseline conditions and during opioid treatment are shown. The population fits give a clear indication of the effect of opioid treatment on the stimulus-NRS relationship with a rightward shift of the curve that differed between nociceptive assays (5% rightward shift for heat pain vs. 46%-55% for electrical pain). In perioperative patients, postoperative curves were 28% shifted to the right relative to preoperative tests. B. Electrical pain Figure 3 . Effect of opioid treatment on penalty score distribution for heat pain (A) and electrical pain (B) models in healthy controls, chronic pain patients, and preoperative and postoperative surgical patients. The penalty scores are divided into 3 cohorts: "good" (scores 0-3.5), "mediocre" (4-7), and "poor" (≥7.5). *P = 0.015, **P = 0.016.
disCussion
In this study, we determined the ability of 3 distinct pain populations (healthy controls without pain, fibromyalgia patients, and perioperative patients) to score experimental pain in a consistent fashion. Most important findings are that the presence of chronic pain and the administration of opioids negatively affect the scoring ability of thermal noxious stimuli and to a lesser extent of electrical stimuli. Moreover, the stimulus-NRS relationship was best described by a sigmoidal function irrespective of stimulus type, disease state, or opioid treatment.
We applied a series of random noxious stimuli to assess scoring capabilities of our participants during exposure to heat and electrical pain. Application of random stimuli has been used previously in pharmacological studies 18, 19 and studies on the validation of various pain-rating scales including VAS and NRS 20, 21 . For example, Ferreira-Valente et al. 20 used cold pressure tests at fixed temperatures (range: 1-7°C) and Herr et al. 21 used fixed heat stimuli (43-51°C) to assess the validity of pain-rating scales in young male vs. female 20 and old vs. young volunteers 21 . We did not apply fixed stimuli but used 8 randomized, blinded stimuli that in terms of intensity were linearly dispersed in between subject-specific pain threshold and tolerance values. We did not correlate the given NRS scores to the assumed values, as we were initially uninformed on the linearity of the NRS. We simply assumed that stimuli with greater intensity would produce higher numerical rating scores. Deviations from this assumption resulted in penalties that could range from 0.5 to 10 per stimulus with a maximum (summed) penalty score of 40 for the train of 8 stimuli (for a graphical explanation, Fig. 1 ). In the population analysis, we observed that the stimulus-response relationships were sigmoidal rather than linear (Fig. 4) . Consequently, the minimum penalty score is most likely >0. Indeed, we observed minimum scores of 0.5 and 1.5 for electrical and heat pain, respectively (Figs. 1C and E) . Consequently, the cohort "good" includes data with scores from 0.5 to 3.5 (electrical pain) and 1.5 to 3.5 (heat pain). Controls without pain were well able to consistently score the random stimuli. Summed penalty scores ≤3.5 (cohort "good") were observed in 73% to 81% of subjects a. Stimulus at which an NRS of 5 is estimated; b. the postoperative value of parameter γ was significantly reduced by factor 0.84 ± 0.03; c. Z = opioid effect on N5 and scores ≥7.5 (cohort "poor") in just 3% to 5% of subjects. The infusion of alfentanil disturbed consistent scoring of heat pain causing a significant shift in cohort distribution with 40% of subjects in cohort "good" and 30% in cohort "poor." In contrast, opioid administration produced no such shift in distribution for the electrical pain model (70% in cohort "good," 5% in cohort "poor"). These data suggest that opioids negatively affect the ability to translate heat pain stimuli into numerical responses, whereas the translation of electrical stimuli is more resistant to the effects of opioids. Opioids produce sedation and consequently affect cognition and hence some deterioration of scoring was expected for both pain models 15 . Additionally, opioids may impact stimulus processing causing a more floating variable that becomes more difficult to score. The 2 pain models differ significantly in their mechanism by which they induce transcutaneous nociceptive stimuli. Electrical stimulation directly excites sensory and nonsensory nerves of the skin in an unnatural and synchronized fashion, bypassing the sensory nerve endings, whereas heat pain selectively activates Aδ and C-fibers at their nerve endings 22 . Consequently, central processing of these 2 distinct stimuli differs. Possibly, processing of the barrage of afferent input from cutaneous electrical stimulation into numerical ratings bypasses opioid-sensitive brain centers involved in this specific function. This hypothesis requires further study. Fibromyalgia patients were less able to consistently score the random stimuli compared with age-matched and sex-matched controls. Summed penalty scores ≤3.5 (cohort "good") were observed in 45% to 67% of patients and scores 4 to 7 (cohort "mediocre") in 27% to 52% of patients. Although relative to controls, the score distributions were worse in both pain models; this reached the level of significance for heat pain but not for electrical pain (Table 2) . Opioids further worsened the penalty score distribution (heat pain 32%, electrical pain 41% in cohort "good"). These are important observations and indicate that chronic pain patients lack the ability to score (experimental) pain in a consistent manner, an effect that is further worsened by opioid treatment. There is evidence that chronic pain induces structural and functional changes in the brain that correlate with impaired cognition 23, 24 . For example, Apkarian et al. 23 showed that chronic low back pain is associated with brain atrophy in the prefrontal cortex and thalamus. Wolrich et al. 8 observed impairment in number sensing in chronic pain patients that may be ascribed to functional changes in the prefrontal and parietal cortices. This, however, is just one part of the complex process of translation of an incoming sensory stimulus into a verbal statement. To properly score pain, patients need to construct an abstract pain scale in their minds and position the incoming painful stimuli on that virtual scale. This requires various cognitive functions such as imagination, retrieval of a numerical memory, ability to size incoming stimuli by comparing them to remembered stimuli, and number sensing. Evidently, even small impairments of cognition may affect any of these processes and hence may hinder the proper scoring of random nociceptive stimuli. Ad-ditionally, our population of chronic pain patients may be affected by small (and large) fiber neuropathy in their skin 25, 26 . These pathophysiological changes may have caused alterations in the afferent input to the spinal cord and brain with consequently modifications in the central processing of the applied experimental stimuli. Moreover, in chronic pain, the continuous but also highly variable nociceptive input from their chronic pain may have further altered central processing with a lesser ability to score the delivered stimuli. These are important issues that merit further study. Because attempts to test both models lead to logistic problems in the perioperative setting, we applied just one nociceptive modality (electrical pain) in our surgical patient population. As expected, baseline penalty score distribution in this ASA 1-2 patient population without chronic pain was similar to that observed in healthy controls with 71% of scores in the cohort "good." Postoperatively the distribution of scores remained unaffected by acute pain (average NRS 4.0) and opioid treatment. These data contrast the observations in chronic pain patients (41% in cohort good during opioid treatment, Table 2 ), an indication that pain per se does not affect pain scoring but that long-term neuroplastic changes in the central and possibly peripheral nervous system are responsible for the observed inadequacy of pain scoring in chronic pain. Our findings are in agreement with those of others 8, 27 and indicate that NRS is a valid tool to describe pain and pain relief from analgesic treatment in postoperative patients. Linear and nonlinear functions were fitted to the data to assess whether the stimulus-response (NRS) relation was linear or sigmoidal. Irrespective of pain modality, study population or opioid treatment, a sigmoidal function provided significant better data fits. A nonlinear relation indicates that the NRS is best not used as relative or percentage change in magnitude of pain sensation because, for example, an increase in NRS from 0 to 1 does not represent a similar change in pain intensity as an increase from 4 to 5, unlike previously suggested 7 . Our analysis further shows the opioid effect on the stimulus-response curves (Fig. 4) . The rightward shift was most pronounced for the electrical pain model with a shift ranging from 28% to 46%. In contrast, the heat pain curves shifted by 5% (parameter Z in Table 4 ). We may have underestimated the effect of the opioid on heat pain curves to some extent, as we did not discriminate between immediate and late pain sensations evoked by the brief heat stimulus. Late pain sensations are most sensitive to opioids 28 . The finding of a lesser opioid effect on heat pain together with the more robust scoring in healthy controls and chronic pain patients likely renders the electrical pain model the more attractive assay for experimental and phase 1 studies of analgesic compounds. Although we applied a randomized design to prevent a learning effect and rotated the heat stimulus between 3 locations on the skin, it remains unclear to what extent the repeated stimulation of the skin has influenced the patients' pain perception. Both adaptation/habituation and sensitization may theoretically have occurred 29 . However, we observed no signs of either manifestation during or after testing in any of our subjects. We applied acute experimental pain stimuli that are intrinsically different from spontaneous pain 30 , and discriminating between intensity levels in real-life pain may be mediated by other factors than tested by us. Irrespective, we contend that our study allows assessment of the reliability of the NRS as scoring tool of acute pain.
In conclusion, consistency to grade experimental pain using an 11-point NRS is high in healthy controls without pain but deteriorates in chronic pain and during opioid administration to healthy volunteers and patients in chronic pain but not in patients with acute pain.
